9LQ-26468-33027
3 vaccinations
4 coded responses
25 check-ins
4 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 31-35
- ZIP prefix
- 070 / NJ
- Registered
- 2021-04-05
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-05
Registered in v-safe
-
2021-04-05
Dose 1 — Moderna
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-09
-
2021-04-10
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising, Injection site erythema — Feeling: Good · Site: RednessFree text: Bruise (size of nickel) appearing at injection site, did not show up previously. Redness (0.3cm diameter) at the center of bruiseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-11
Survey response — days 1–6 daily, dose 1MedDRA: Contusion, Erythema — Feeling: Good · Site: Redness · Fatigue or tirednessFree text: Bruise was yellowish-grey yesterday. Slightly larger today (+0.3mm diameter) but color looks better (pale yellowish grey). Redness in center on change in size but looks better (paler redMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-12
Survey response — day 7, dose 1MedDRA: Injection site bruising — Feeling: Good · Site: RednessFree text: Same bruise at injection size,no change in size/color from previous dayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-19
- 2021-04-26
-
2021-05-03
Dose 2 — Moderna
- 2021-05-03
-
2021-05-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fever · Fatigue or tiredness · Be unable to workAdult check-in
- 2021-05-06
- 2021-05-07
- 2021-05-08
- 2021-05-09
- 2021-05-10
- 2021-05-17
- 2021-05-24
- 2021-05-31
- 2021-06-07
- 2021-06-14
- 2021-08-02
-
2021-11-01
Survey response — 6 months, dose 2MedDRA: Dizziness, Headache, Hyposmia, SARS-CoV-2 antibody test negative, SARS-CoV-2 test negative — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Mid August: 80% loss of smell, headache, dizzyness. Antigen/ Pcr/antibody covid, all negative, so unlikely covidMedDRA releases: 2024-11 · check-in free text available
-
2021-11-01
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-11-03
-
2021-12-03
Dose 3 — Pfizer-BioNTech
- 2022-06-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-05 | Moderna | |
| 2 | 2021-05-03 | Moderna | |
| 3 | 2021-12-03 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Bruise (size of nickel) appearing at injection site, did not show up previously. Redness (0.3cm diameter) at the center of bruise
Systemic reaction (other): Bruise was yellowish-grey yesterday. Slightly larger today (+0.3mm diameter) but color looks better (pale yellowish grey). Redness in center on change in size but looks better (paler red
Release 7 — day 7, dose 1
Systemic reaction (other): Same bruise at injection size,no change in size/color from previous day
Release 10 — 6 months, dose 2
Symptoms: Mid August: 80% loss of smell, headache, dizzyness. Antigen/ Pcr/antibody covid, all negative, so unlikely covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dizziness | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hyposmia | · | · | ✓ |
| SD | SARS-CoV-2 antibody test negative | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Contusion | ✓ | ✓ | ✓ |
| SRO | Erythema | ✓ | ✓ | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Injection site erythema | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release